ABSTRACT: A facile and efficient route for the synthesis of 2,4-disubstituted imidazoles from benzimidamides and vinyl azides through [3 + 2] cyclization under catalyst-free conditions has been described. The method is compatible for a broad range of functional groups with good to excellent yields.
■ INTRODUCTION
Imidazoles are the most valuable five-membered heterocyclic compounds found in many natural products, biological systems, pharmaceuticals, and agro chemicals.
1,2 Additionally, imidazole derivatives have been reported to possess pharmacological properties such as antiplasmodial, 3 antitumor, 4 and antifungal. 5 Consequently, many efforts have been made in the past decade on the synthesis of those privileged scaffolds. The reported methods include reaction of amidines with halo (nitro)alkenes, 6 haloketones, 7 alkyne/haloakynes, 8 and other methods.
9
Although these methods are elegant and appear to be developed specifically for obtaining multisubstituted imidazole derivatives, in organic synthesis, the site-selective synthesis of the desired products is still an attractive and challenging task. Our intention is to develop a method for selective synthesis of 2,4-disubstituted imidazoles using easily available starting reagents under mild reaction conditions. Hence, the synthesis of imidazoles with free N−H and C-5 position for further (N1 and C-5) functionalization of such scaffolds is of continued interest.
■ RESULTS AND DISCUSSION
Despite these advances, to our knowledge, the oxidative cyclization of vinyl azides with benzamidines has remained elusive in literatures. In continuation of our studies on the synthesis of fused N-heterocycles, 10 we report herein a facile method for the synthesis of 2,4-disubstituted imidazoles with 1,8-diazabicyclo (5, 4, promoted by the oxidative cyclization of vinyl azides with benzamidines under mild conditions (Scheme 1).
We began our study by taking benzimidamide hydrochloride (1a) and (1-azidovinyl) benzene (2a) as the model substrates. The results are summarized in Table 1 . Initially, the reaction of 
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Article the desired product 3a was isolated ( Under the optimized reaction conditions, the scope and generality of the reaction were investigated and the results are summarized in Scheme 2. Initially, we performed the reaction of benzimidamide hydrochloride (1a) with various vinyl azides 2 and the reactions were found to be very facile with both electron-rich and electron-deficient groups (−Me, −OMe, −tBu, −Br, and −F) at the para position of vinyl azides and the desired products 3b−f were obtained in good to excellent yields (80−94%). One of the product 3f was also confirmed by the single-crystal X-ray diffraction analysis (CCDC No. 1556865) . The presence of −NO 2 , −Me, or −OMe group at either the ortho or meta position of vinyl azides produced the corresponding products 3g−j in moderate to good yields (67−79%).
To expand the scope of the present transformation, we explored the reactivity of the substituted benzamidines substrate with various vinyl azides, and the results are compiled in Scheme 3. The electron-donating and electron-withdrawing (−Me, −Br, −Cl, and −NO 2 ) substituents at the para position of benzamidine reacted smoothly with (1-azidovinyl) benzene and produced the corresponding products 5a−d in good yields (66−87%). Interestingly, the presence of strong electrondonating benzamidines such as 4-aminobenzimidamide hydrochloride and 4-hydroxybenzimidamide hydrochloride reacted with 2a and gave the products 5e and 5f in 70 and 33% yields, respectively. Interestingly, the procedure is amenable to nicotinimidamide hydrochloride and cyclopropane carboximidamide and affords the differently decorated products 5g and 5h in 60 and 72% yield, respectively. Additionally, we evaluated the substrate scope of various benzamidines as well as vinyl azides (having both electron-rich and electron-deficient groups in both the rings at either position ortho/meta/para), which afforded the desired products 5i−r in good yields (63−92%). The presence of electron-releasing groups (5n), electronwithdrawing groups (5o and 5p), or halogens (5l and 5o) on both the rings provided good yields of products. The results from Schemes 2 and 3 demonstrate the versatility of the reactions with a high degree of functional group tolerance and with a broad substrate scope. It may be noted that halidesubstituted derivatives were well tolerated and could be further applied in traditional cross-coupling reactions. Unfortunately, the present transformation is not suitable for aliphatic benzimidamides with vinyl azide.
To validate the process for scale-up studies (gram scale), we performed the reaction of 1a with 1-(1-azidovinyl)-4-bromobenzene under optimized conditions and obtained the corresponding product 3f in 72% yield (2.15 g) (Scheme 4). This study indicates the feasibility of the method for industrial/ commercial production.
To gain further insight into the reaction mechanism, some control experiments were performed (Scheme 5). The reaction of N-phenylbenzimidamide 6a was subjected with 2a under standard conditions, expect product 7a was not observed (Scheme 5, eq 1). This reaction suggests that the free NH 2 group (of amidine) is essential for such a transformation. Further, the reaction of 1a with (1-bromovinyl) benzene (8) was conducted under optimized conditions; no reaction was observed, but 91% of 8 was recovered (Scheme 5, eq 2). It indicates that the direct removal of azide was not possible; the reaction may proceed via nitrene intermediate from vinyl azide (Scheme 5, eq 3). To ascertain whether the reaction proceeds by radical pathway or not, the reaction of 1a and 2a was checked with 2,2,6,6-tetramethylpiperidine-1-oxyl radical under optimized conditions, 86% of 3a was isolated. This rule outs the radical reaction route. Finally, benzimidamide 9 subjected with 2a in CH 3 CN without DBU, 91% of the desired product 3a was obtained (Scheme 5, eq 4). This reaction and eq 1 (Scheme 5) together clarify the necessity of NH 2 (amidine) in the present transformation. Hence, the role of DBU is to neutralize the hydrochloride of 1a (benzimidamide hydrochloride).
On the basis of the control experiments and literature reports, 11 a plausible reaction mechanism has been proposed (Scheme 6). Initially, benzimidamide hydrochloride (1a) neutralization by base (DBU) gives benzimidamide 9. The ■ CONCLUSIONS
In conclusion, we have demonstrated a new simple method for the synthesis of 2,4-disubstituted imidazole derivatives through [3 + 2] cyclization of benzamidines with vinyl azides. This methodology is applicable for the selective synthesis of 2,4-disubstituted imidazoles in good to excellent yields, with a high degree of functional group tolerance.
■ EXPERIMENTAL SECTION General Information. All of the commercially available chemicals and reagents were used without any further purification unless otherwise indicated. General Procedure for 3a. Benzimidamide hydrochloride 1a (47 mg, 0.3 mmol), (1-azidovinyl) benzene 2a (29 mg, 0.2 mmol), and DBU (45.6 mg, 0.3 mmol) were taken in a 10 mL reaction tube; to the mixture, 2.0 mL of acetonitrile was added. The reaction tube was placed in a preheated oil bath at 80°C for 8 h (progress of the reaction was monitored by TLC). Then, the reaction mixture was allowed to attain room temperature; 10.0 mL of brine solution was extracted with ethyl acetate (3 × 15 mL) and dried with anhydrous Na 2 SO 4 . After the removal of solvent, the crude mixture was subjected to column chromatography on silica gel and 89% yield of the product 2,4-disubstituted imidazole (39.2 mg) 3a was isolated. (All of the vinyl azides employed in the present work were prepared by known procedure.
12 )
Characterization Data. 2,4-Diphenyl-1H-imidazole (3a). 
4-(4-Bromophenyl)-2-phenyl-1H-imidazole (3f).
(Eluent: 10% EtOAc/hexane); 80% yield (47.9 mg); yellow solid; 1 H NMR (600 MHz, CD 3 OD) δ 7.90 (d, J = 6.5 Hz, 2H), 7.67 (d, J = 7.0 Hz, 2H), 7.50 (s, 1H), 7.48 (d, J = 2.5 Hz, 2H), 7.44 (t, J = 6.0, 2H), 7.37 (t, J = 6.0 Hz, 2H), 7.37 (t, J = 6.0 Hz, 1H).
13 C NMR (150 MHz, CD 3 OD) δ 147. 7, 131.4, 130.0, 128.63, 126.60, 126.4, 125.4, 120.0 4, 130.8, 128.8, 128.7, 128.3, 127.4, 126.0, 125.2, 29.7 . HRMS calcd for C 16 H 15 N 2 : 235.1235. Found: 235.1241.
4-(2-Methoxyphenyl)-2-phenyl-1H-imidazole (3h).
(Eluent: 10% EtOAc/hexane); 67% yield (33.5 mg); light yellow solid; 1 H NMR (500 MHz, CDCl 3 ) δ 7.88 (d, J = 7.5 Hz, 2H), 7.58 (s, 1H), 7.45 (t, J = 7.5, 2H), 7.36 (t, J = 7.5 Hz, 1H), 7.26 (q, J = 7.5, 2H), 7.06 (m, 2H), 4.02 (s, 3H).
13
C NMR (125 MHz, CDCl 3 ) δ 140. 0, 128.8, 128.4, 124.9, 121.5, 111.4, 103.5, 55.8 9, 138.3, 128.8, 128.68, 128.61, 127.8, 125.5, 125.2, 121.9, 21.4 4, 130.8, 129.5, 129.2, 129.0, 125.3, 121.4, 119.6 2-(4-Bromophenyl)-4-phenyl-1H-imidazole (5b).
(Eluent: 10% EtOAc/hexane); 85% yield (50.7 mg); yellow solid; melting point 198°C 1 H NMR (500 MHz, CDCl 3 ) δ 7.72 (t, J = 8.0 Hz, 4H), 7.52 (d, J = 8.0 Hz, 2H), 7.40 (q, J = 7.5 Hz, 3H), 7.28 (t, J = 7.5 Hz, 1H).
C NMR (125 MHz, CDCl 3 ) δ 146. 0, 132.0, 128.9, 128.7, 127.2, 126.7, 124.9, 128.8 . HRMS calcd for C 15 H 12 N 2 Br: 299.0184. Found: 299.0186.
2-(4-Chlorophenyl)-4-phenyl-1H-imidazole (5c).
(Eluent: 10% EtOAc/hexane); 81% yield (41.3 mg); white solid; 1 H NMR (600 MHz, CD 3 OD) δ 7.88 (d, J = 6.5, Hz, 2H), 7.73 (d, J = 6.5 Hz, 2H), 7.44 (d, J = 6.0 Hz, 3H), 7.37 (t, J = 6.5 Hz, 2H), 7.23 (t, J = 6.0 Hz, 1H).
13 C NMR (150 MHz, CD 3 OD) δ 145. 9, 134.6, 131.2, 129.1, 128.7, 128.6, 128.5, 126.4, 124.9 . HRMS calcd for C 15 H 12 N 2 Cl: 255.0689. Found: 255.0694.
2-(4-Nitrophenyl)-4-phenyl-1H-imidazole (5d). 13 C NMR (150 MHz, CD 3 OD) δ 146. 3, 134.2, 128.84, 128.73, 128.4, 126.8, 124.7 . HRMS calcd for C 15 H 12 N 3 O 2 : 266.0930 Found: 266.0928.
4-(4-Phenyl-1H-imidazol-2-yl)aniline (5e).
(Eluent: 75% EtOAc/hexane); 70% yield (33.1 mg); gray color solid; melting point 199°C. 4-(4-Phenyl-1H-imidazol-2-yl)phenol (5f).
(Eluent: 65% EtOAc/hexane); 33% yield (15.7 mg); white color solid; 1 H NMR (600 MHz, DMSO-d 6 ) δ 12.3 (s, 1H), 9.65 (s, 1H), 7.79 (q, J = 6.5 Hz, 4H), 7.61 (s, 1H), 7.31 (t, J = 6.5, 2H), 7.14 (t, J = 6.0 Hz, 1H), 6.80 (d, J = 7.0, 2H).
13
C NMR (150 MHz, DMSO-d 6 ) δ 158. 1, 135.4, 128.9, 127.0, 126.4, 124.7, 122.4, 115.9, 113.8 3-(4-Phenyl-1H-imidazol-2-yl)pyridine (5g). 8, 146.0, 143.2, 141.4, 134.2, 132.0, 128.8, 128.4, 126.3, 124.3, 123.7, 114.9 . HRMS calcd for C 14 H 12 N 3 : 221.1031. Found: 221.1026.
2-Cyclopropyl-4-phenyl-1H-imidazole (5h).
(Eluent: 30% EtOAc/hexane); 72% yield (26.5 mg); white solid; melting point 160°C. 1 H NMR (600 MHz, CDCl 3 ) δ 7.64 (broad peak, 2H), 7.35 (t, J = 6.5,2H), 7.21 (t, J = 6.5, 1H), 7.16 (s, 1H), 1.99−1.94 (m, 1H), 1.02−0.95 (m, 4H) . 13 C NMR (150 MHz, CDCl 3 ) δ 128. 7, 126.7, 124.7, 9.24, 7.44. HRMS calcd for C 12 H 13 N 2 : 185.1079 . Found: 185.1077 -2-(p-tolyl)-1H-imidazole (5i).
(Eluent: 10% EtOAc/hexane); 87% yield (43.8 mg); white solid; melting point 180°C. 1 H NMR (600 MHz, CDCl 3 ) δ 7.75 (t, J = 7.0 Hz, 4H), 7.27 (d, J = 8.5 Hz, 1H), 7.22 (d, J = 6.5, 2H), 7.06 (t, J = 7.0 Hz, 2H), 2.37 (s, 3H).
C NMR (150 MHz, CDCl 3 ) δ 162.8 (d, J = 203.6), 138.9, 129.5, 127.2, 126.60 (d, J = 6.37 Hz), 125.1, 115.6 (d, J = 17.7 Hz) 8, 147.2, 144.9, 144.8, 140.6, 136.4, 131.2, 130.7, 126.3, 124.9, 121.6, 119.0, 118.6 4-(4-Chlorophenyl)-2-cyclopropyl-1H-imidazole (5m). 13 C NMR (150 MHz, DMSO-d 6 ) δ 130. 7, 125.8, 124.0, 123.0, 113.4, 9.6, 7.5 4, 126.7, 125.6, 124.4, 114.1, 31.7 7, 147.5, 145.4, 135.5, 130.4, 129.5, 125.7, 123.7, 121.0, 118.9 
2-(4-Chlorophenyl)-4-(o-tolyl)-1H-imidazole (5r).
(Eluent: 10% EtOAc/hexane); 70% yield (37.6 mg); light yellow solid; melting point 191°C. 1 H NMR (600 MHz, CD 3 OD) δ 7.80 (d, J = 7.5 Hz, 2H), 7.43 (m, 2H), 7.36 (d, J = 6.5, 2H), 7.18 (m, 2H), 7.14 (m, 2H), 7.10 (s, 1H) 2.34 (s, 3H).
13 C NMR (150 MHz, CDCl 3 ) δ 145. 5, 135.7, 134.2, 130.3, 128.8, 128.7, 127.3, 126.7, 125.5, 19.8 The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.7b00969.
Copies of NMR spectra for all of the compounds and HRMS spectra for all of the compounds (PDF) Crystallographic data (CIF)
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